Mynosys Cellular Devices said today that it raised $25 million for its Zepto cataract device and named ex-Tear Film Innovations chief Rob Thornhill to be its new CEO. Fremont, Calif.-based Mynosys said the new funding round, led by Decheng Capital, is earmarked for growing its U.S. commercial footprint, R&D, manufacturing and commercial organization. Decheng’s Dr. […]
Mynosys Cellular Device
Mynosys wins CE Mark for Zepto capsulotomy device
Mynosys Cellular Devices said yesterday it won CE Mark approval in the European Union for its Zepto device for performing anterior lens capsulotomies during cataract surgery. The device is designed to produce round, accurately sized, centered capsulotomies during the surgical routine through the use of highly focused multi-pulse low-energy discharge along 360 degrees, the Fremont, […]